Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
We target how the disease develops and progresses
We create precise, predictive digital health solutions
We build solutions to ensure all Canadians can receive expert care
It strikes over 1 million Canadians and costs the system over $3 billion a year.
We must talk about this. And we must empower those who live with it.
We develop a diverse generation of scientists, clinicians, engineers and entrepreneurs
We take risks on high-reward projects at investigator and trainee levels
We drive new discoveries through to commercialization and clinical impact
A unique institute dedicated to solving heart failure via innovation and collaboration at three world-class partners: Canada’s top children’s hospital, biggest hospital, and biggest university.
Our multidisciplinary teams take aim at heart failure through expertise in regenerative medicine, data science, genomics, remote technologies, and transformative care.
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in...